AXIAL SPONDYLARTHRITIS (AXSPA)
Clinical trials for AXIAL SPONDYLARTHRITIS (AXSPA) explained in plain language.
Never miss a new study
Get alerted when new AXIAL SPONDYLARTHRITIS (AXSPA) trials appear
Sign up with your email to follow new studies for AXIAL SPONDYLARTHRITIS (AXSPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could shine a light on hidden inflammation
Diagnosis Recruiting nowThis study is testing a new radioactive tracer called [18F]AlF-FAPI-74 for PET/CT scans to see if it can find inflammation better than the current standard tracer. The trial will involve 140 people with fever of unknown origin, IgG4-related disease, or axial spondylarthritis. Res…
Matched conditions: AXIAL SPONDYLARTHRITIS (AXSPA)
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC
-
New blood test could end Trial-and-Error for arthritis drugs
Diagnosis Recruiting nowThis study is testing a new blood-based test that aims to predict which medication will work best for each person with rheumatic diseases like rheumatoid arthritis or lupus. Researchers will take a blood sample and analyze immune cells to create a personalized treatment profile. …
Matched conditions: AXIAL SPONDYLARTHRITIS (AXSPA)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated Jun 26, 2026 13:02 UTC
-
700 patients to reveal how new arthritis drugs perform in the real world
Knowledge-focused Recruiting nowThis study will follow 700 adults with axial spondyloarthritis or psoriatic arthritis who have recently started one of several newer treatments (bimekizumab, upadacitinib, risankizumab, guselkumab, or a TNF inhibitor). Researchers will collect medical records and patient surveys …
Matched conditions: AXIAL SPONDYLARTHRITIS (AXSPA)
Sponsor: Adelphi Real World • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:21 UTC